Johnson & Johnson's Spravato nasal spray has been FDA-approved as a stand-alone therapy for adults with treatment-resistant ...
CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...
Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.
The Food and Drug Administration on Tuesday approved Johnson & Johnson's nasal spray to be used alone in adults with a major ...
Researchers delivered a dose of the “love hormone” oxytocin via a nasal spray to participants and found that it decreased ...
The nasal spray has undergone more than a decade of ... be linked to Alzheimer's risk Delays in dreaming might be an early warning sign of Alzheimer's disease. Health News // 18 hours ago Report ...
J&J made it into a nasal spray to get it into the brain quickly ... they're feeling somewhat better" with Spravato. Spravato's warning label cautions about the risk of sedation and dissociation ...